News
Eli Lilly, Novo Nordisk and Zepbound
Digest more
Now, this won't come as too much of a surprise to Eli Lilly and its peers. A few weeks ago, the company's CEO, David Ricks, ...
Stocks rose sharply Monday after the U.S. and China said Monday they had reached an agreement over the weekend to temporarily ...
The Lilly announcement will extend an agreement aimed at accelerating medicine development and bolstering the ...
Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.
Eli Lilly and Company (NYSE: LLY) and Purdue University announced today a significant expansion of their long-standing alliance, with Lilly's planned investment of up to $250 million in the ...
The ALS therapy ATLX-1282 was developed with AIchemab's platform, which uses AI to identify therapeutic targets for difficult ...
Explore more
Eli Lilly and Purdue University expand their partnership with a $250 million investment to advance pharmaceutical innovation ...
Growth stocks often don't come cheap, especially when their prospects look great, as is the case with Eli Lilly ( LLY 1.09%).
3don MSN
The investment over the next eight years could be the largest ever industry-academic agreement of its kind in the U.S., the ...
We came across a bullish thesis on Eli Lilly and Company (LLY) on Substack by Kontra. In this article, we will summarize the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results